Copying and distributing are prohibited without permission of the publisher.

Watermark

China's BeiGene prices $200m follow-on

capsule px230
By Jonathan Breen
18 Nov 2016

Chinese biopharmaceutical company BeiGene has net $200m from a follow-on public offering of American Depositary Shares (ADSs).

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Jonathan Breen
18 Nov 2016